BioCentury
ARTICLE | Company News

Pepscan Holding, Zealand Pharma inflammation, gastrointestinal news

March 28, 2011 7:00 AM UTC

Zealand and Pepscan's Pepscan Therapeutics B.V. subsidiary will collaborate over the next two years to identify a lead dual acting peptide candidate to enter preclinical development for chronic infla...